FIELD: biotechnology.
SUBSTANCE: invention relates to peptide thrombolytics and can be used in medicine in treating thrombosis. Disclosed is use of polypeptide with SEQ ID NO: 9 or SEQ ID NO: 10 as an agent which recognizes an intravascular thrombus and dissolves the intravascular thrombus.
EFFECT: invention provides thrombus dissolution in mammal’s blood without serious side effects in the form of bleeding, thus possessing preventive and therapeutic efficacy against thrombosis.
1 cl, 10 dwg, 6 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| POLYPEPTIDE FOR TREATING PATHOLOGICAL BLOOD CLOTS | 2019 |
|
RU2778566C1 |
| ANTIBODIES AGAINST HtrA1 AND METHODS OF THEIR APPLICATION | 2016 |
|
RU2750285C2 |
| ANTIBODIES TO FACTOR XI | 2017 |
|
RU2800719C2 |
| PEPTIDE FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION | 2017 |
|
RU2788083C2 |
| NEW ANTIBODIES AGAINST XI FACTOR AND THEIR APPLICATIONS | 2017 |
|
RU2758160C2 |
| ANTIBODIES AGAINST XI CLOTTING FACTOR | 2017 |
|
RU2757314C2 |
| PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTING AND/OR TREATING A DISEASE THAT DEVELOPS OR PROGRESSES AS A RESULT OF REDUCING OR LOSING ACTIVITY OF THE BLOOD COAGULATION FACTOR VIII AND/OR ACTIVATED COAGULATION FACTOR VIII | 2015 |
|
RU2721910C2 |
| EMBODIMENTS OF IGG-Fc FOR USE IN VETERINARY SCIENCE | 2018 |
|
RU2814952C2 |
| BISPECIFIC ANTIBODY HAVING HIGH ACTIVITY, ALTERNATIVE FUNCTION OF COFACTOR FVIII | 2017 |
|
RU2821642C2 |
| FUSED PROTEIN CONSTRUCTS FOR COMPLEMENT-RELATED DISEASE | 2019 |
|
RU2824402C2 |
